Shivom: Defining the Genomics Blockchain Industry

danny_yell

Shivom is creating a medical genomics ecosystem on the blockchain and will offer an open web marketplace for other healthcare providers to add their apps and services alongside genomic data analytics and personalised medicine.

Shivom is a venture that intends to utilize the securitization of data inside blockchain development to connect with another time of genomics. The social protection stage will consider a genomic organic group where customers will have an open web business community for modified medicine, genomic data examination, and prosperity organizations applications. The gathering behind the undertaking envision a transformational meeting of the OMICS advancements with AI, machine learning methods, and blockchain to consider the overall adaptability in therapeutic administrations. The blockchain advancement is at this moment the primary development with respect to settling our insurance issues. The ability to pass on secure exchanges without center individuals is showing useful in various ventures including land, reserve, prosperity and now genomics. Clearly formally a couple of wellbeing associations are betting on the prerequisite for genomic data and placing assets into genomic data dare to meet the advancement.

Problem

• Genome sequencing had been previously expensive but costs are drastically reducing making sequencing more readily available.

• With increase in donors there are issues around data ownership, data sharing and data integrity.

• Genomic sequencing providers often sell genomic data for their own profit whilst donors aren’t compensated in any way.

The Vision of Shivom

Animate the age of the genomics

Each 7.6 billion people on earth have a unique code set away in their characteristics that reveal the special experiences of appearance, heredity, insightful limit, prosperity, and wellbeing. In any case, the limit of this code to reveal a slant to the sickness has been overlooked.

Upgrade overall prosperity

At the present time is a perfect open door for gather change for the "genome" trial of the coming decade. At present, some key players hold a forcing plan of action on genome data and make gigantic advantages from pitching it to pariahs, when in doubt without salary conferring to data benefactors.

Commence exactness based medicine genome

We change the movement of the overall therapeutic administrations publicize. We utilize the most created progresses including blockchain, appropriated registering, genome sequencing, mechanized thinking, and significant data examination to bring the restorative genome into another period.

Assurance the accompanying level of data security

We are at the cutting edge of data security. We use front line cryptography to add additional security levels to our stage that go past blockchain advancement for decentralization, protecting every customer's data from cybercriminals.

Shivom's Solution

To achieve its target of a comprehensive database for DNA courses of action, Shivom will utilize the blockchain development to make a real, and free natural framework. With this conviction framework, Shivom will guarantee the fragile genomic data which is yet to happen with our standard databases. Likewise, the human administrations zone is set to value a course of action of favorable circumstances that go with beating the trial of an ensured structure. These will join;

More straightforward access and limit of the genome data in a single place

Better organization and control of how the information is gotten to

Prosperity investigators can use the information to find lifestyle information

The likelihood to perceive prosperity conditions before they end up authentic

Engages the customer to get a motivation for their data through tokenization and brilliant contracts

Shivom Platform

1 ClaMH0RdO8WbJFutqwN1fw.png

Genomics and automated thinking exhibit a novel chance to change R&D programs, particularly screening for quiet targets and differentiating medicine hopefuls. The fundamental cost related with quiet movement is related with the ability to get to high measure and embraced datasets from patients. We are beginning at now amazing with extras in driving pharmaceutical/biotech affiliations and clinical research affiliations (CROs) to enable access to our associations, and moreover offer the chance to help genomic testing on a mass level. The information won't be ensured by any affiliation, and the Shivom stage will engage pharmaceutical affiliations' utilization of the information by giving engaging prizes and a market find the opportunity to demonstrate that immediate draws in with information proprietors. The model will engage access to study and control patients through an application business put for phenotypic screening and that is only a trace of a more noteworthy test.

The advancement rate of genomic data securing over the span of the latest decade has been truly amazing, with the total entirety of course of action data conveyed increasing generally predictably.

Shivom Roadmap

The OmiX Token

The OmiX token is a key part that engages acquiring, trading, boosting and diverse organizations. The token is the fuel of the Shivom condition, and part of the organization of the structure.

Token Sale

990M OmiX tokens will be sold in the midst of the ICO technique.

Gathering

90M OmiX Tokens will be passed on to the gathering to create and bolster the Shivom natural framework, for wealth undertakings to utilize compose impacts, and for assemble exercises to compensate designers, business people, and strategists.

Team

Co-Founder & CEO – Dr Axel Schumacher

Axel has vast experience in this field, which includes writing the ‘Blockchain and Healthcare Strategy Guide’. He has a Ph.D. in Human Genetics and is a member of the Blockchain Research Institute..

Co-Founder & COO – Gourish Singla

Gourish has a background in investment banking and has founded his own chemicals company as well as another 3 in the digital health space. Her areas of expertise are blockchain, AI, machine learning and robotics.

Co-Founder & CMO - Sally Eaves

Sally has held positions as a Chief Technology Officer, Practising Professor of FinTech and Global Strategic Advisor. She has consistently been rated in the top 10 for blockchain and social media influence worldwide.

Co-Founder & CSO – Per Lind

Per is the Co-Founder of IOTA Foundation and specialises in engaging social marketing.

Co-Founder & CTO – Akash Gaurav

Akash is a blockchain entrepreneur and founded India’s first blockchain company, Auxesis Group. Auxesis Group is considered amongst the Top 100 Most Influential Blockchain Companies in the world.

Co-Founder & Chief Technology Advisor

Kumar is the founder of Cashaa, a blockchain based payment and banking startup and the Chairman of Auxesis Group.

Chief Scientific Officer – Dr Natalie Pankova

Natalie has been the Director of 2 early stage health-tech companies. She holds a Ph.D. from the Faculty of Medicine at the University of Toronto. Her research focus was on ophthalmology, inflammatory diseases, diagnostics and personalised medicine.

For more information:

Website :https://shivom.io/

Whitepaper :https://shivom.io/files/Shivom-Executive-Summary.pdf

Facebook :https://www.facebook.com/ProjectShivom

Twitter :https://twitter.com/projectshivom

Telegram :https://t.me/projectshivom

Reddit :https://www.reddit.com/r/Shivom/

Youtube :https://www.youtube.com/c/ProjectShivom

Instagram :https://www.instagram.com/projectshivom

For more information:

Website :https://shivom.io/

Whitepaper :https://shivom.io/files/Shivom-Executive-Summary.pdf